Biopharmaceutical CRO - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Service & Software > Biopharmaceutical CRO - Global Top Players Market Share and Ranking 2025

Biopharmaceutical CRO - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-26
Report Id: 2854745
Industry: Service & Software
Report Page: 117
Chart: 120

PDF Download

Publication Date: 2025-11-26
Report Id: 2854745
Industry: Service & Software
Report Page: 117
Chart: 120

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Biopharmaceutical CRO Definition
1.2 Global Biopharmaceutical CRO Market Size and Forecast
1.3 China Biopharmaceutical CRO Market Size and Forecast
1.4 Share of China Biopharmaceutical CRO Market with Respect to the Global Market
1.5 Biopharmaceutical CRO Market Size: China VS Global Growth Rate, 2020-2031
1.6 Biopharmaceutical CRO Market Dynamics
1.6.1 Biopharmaceutical CRO Market Drivers
1.6.2 Biopharmaceutical CRO Market Restraints
1.6.3 Biopharmaceutical CRO Industry Trends
1.6.4 Biopharmaceutical CRO Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Biopharmaceutical CRO, Global Market Share by Company, 2020-2025
2.2 Global Biopharmaceutical CRO Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biopharmaceutical CRO Concentration Ratio
2.4 Global Biopharmaceutical CRO Mergers & Acquisitions, Expansion Plans
2.5 Global Biopharmaceutical CRO Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Biopharmaceutical CRO, China Market Share by Company, 2020-2025
3.2 China Biopharmaceutical CRO Biopharmaceutical CRO Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Biopharmaceutical CRO Industry Chain
4.2 Biopharmaceutical CRO Upstream Analysis
4.2.1 Biopharmaceutical CRO Core Raw Materials
4.2.2 Main Manufacturers of Biopharmaceutical CRO Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Biopharmaceutical CRO Production Mode
4.6 Biopharmaceutical CRO Procurement Model
4.7 Biopharmaceutical CRO Industry Sales Model and Sales Channels
4.7.1 Biopharmaceutical CRO Sales Model
4.7.2 Biopharmaceutical CRO Typical Distributors

5 Sights by Type
5.1 Biopharmaceutical CRO Classification by Type
5.1.1 Full-service CRO
5.1.2 Specialized CRO
5.2 by Type, Global Biopharmaceutical CRO Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Biopharmaceutical CRO Consumption Value, 2020-2031

6 Sights by Class
6.1 Biopharmaceutical CRO Classification by Class
6.1.1 Preclinical Research CRO
6.1.2 Clinical Trial CRO
6.1.3 CMC & Manufacturing Support CRO
6.2 by Class, Global Biopharmaceutical CRO Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Class, Global Biopharmaceutical CRO Consumption Value, 2020-2031

7 Sights by Treatment Type
7.1 Biopharmaceutical CRO Classification by Treatment Type
7.1.1 Biologics CRO Support
7.1.2 Cell & Gene Therapy CRO
7.1.3 mRNA & Vaccine CRO
7.2 by Treatment Type, Global Biopharmaceutical CRO Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Treatment Type, Global Biopharmaceutical CRO Consumption Value, 2020-2031

8 Sights by Application
8.1 Biopharmaceutical CRO Segment by Application
8.1.1 SMBs
8.1.2 Large Enterprises
8.2 by Application, Global Biopharmaceutical CRO Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Application, Global Biopharmaceutical CRO Consumption Value, 2020-2031

9 Sales Sights by Region
9.1 By Region, Global Biopharmaceutical CRO Consumption Value, 2020 VS 2024 VS 2031
9.2 By Region, Global Biopharmaceutical CRO Consumption Value, 2020-2031
9.3 North America
9.3.1 North America Biopharmaceutical CRO Market Size & Forecasts, 2020-2031
9.3.2 By Country, North America Biopharmaceutical CRO Market Size Market Share
9.4 Europe
9.4.1 Europe Biopharmaceutical CRO Market Size & Forecasts, 2020-2031
9.4.2 By Country, Europe Biopharmaceutical CRO Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific Biopharmaceutical CRO Market Size & Forecasts, 2020-2031
9.5.2 By Country/Region, Asia Pacific Biopharmaceutical CRO Market Size Market Share
9.6 South America
9.6.1 South AmericaBiopharmaceutical CRO Market Size & Forecasts, 2020-2031
9.6.2 By Country, South America Biopharmaceutical CRO Market Size Market Share
9.7 Middle East & Africa

10 Sales Sights by Country Level
10.1 By Country, Global Biopharmaceutical CRO Market Size & CAGR, 2020 VS 2024 VS 2031
10.2 By Country, Global Biopharmaceutical CRO Consumption Value, 2020-2031
10.3 United States
10.3.1 United States Biopharmaceutical CRO Market Size, 2020-2031
10.3.2 by Type, United States Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.3.3 by Application, United States Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.4 Europe
10.4.1 Europe Biopharmaceutical CRO Market Size, 2020-2031
10.4.2 by Type, Europe Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.4.3 by Application, Europe Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.5 China
10.5.1 China Biopharmaceutical CRO Market Size, 2020-2031
10.5.2 by Type, China Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.5.3 by Application, China Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.6 Japan
10.6.1 Japan Biopharmaceutical CRO Market Size, 2020-2031
10.6.2 by Type, Japan Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.6.3 by Application, Japan Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.7 South Korea
10.7.1 South Korea Biopharmaceutical CRO Market Size, 2020-2031
10.7.2 by Type, South Korea Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.7.3 by Application, South Korea Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.8 Southeast Asia
10.8.1 Southeast Asia Biopharmaceutical CRO Market Size, 2020-2031
10.8.2 by Type, Southeast Asia Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.8.3 by Application, Southeast Asia Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.9 India
10.9.1 India Biopharmaceutical CRO Market Size, 2020-2031
10.9.2 by Type, India Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.9.3 by Application, India Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.10 Middle East & Africa
10.10.1 Middle East & Africa Biopharmaceutical CRO Market Size, 2020-2031
10.10.2 by Type, Middle East & Africa Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031
10.10.3 by Application, Middle East & Africa Biopharmaceutical CRO Consumption Value Market Share, 2024 VS 2031

11 Company Profile
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Information, Head Office, Market Area, and Industry Position
11.1.2 WuXi AppTec Company Profile and Main Business
11.1.3 WuXi AppTec Biopharmaceutical CRO Models, Specifications, and Application
11.1.4 WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.1.5 WuXi AppTec Recent Developments
11.2 WuXi Biologics
11.2.1 WuXi Biologics Company Information, Head Office, Market Area, and Industry Position
11.2.2 WuXi Biologics Company Profile and Main Business
11.2.3 WuXi Biologics Biopharmaceutical CRO Models, Specifications, and Application
11.2.4 WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.2.5 WuXi Biologics Recent Developments
11.3 Hangzhou Tigermed
11.3.1 Hangzhou Tigermed Company Information, Head Office, Market Area, and Industry Position
11.3.2 Hangzhou Tigermed Company Profile and Main Business
11.3.3 Hangzhou Tigermed Biopharmaceutical CRO Models, Specifications, and Application
11.3.4 Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.3.5 Hangzhou Tigermed Recent Developments
11.4 Pharmaron Beijing
11.4.1 Pharmaron Beijing Company Information, Head Office, Market Area, and Industry Position
11.4.2 Pharmaron Beijing Company Profile and Main Business
11.4.3 Pharmaron Beijing Biopharmaceutical CRO Models, Specifications, and Application
11.4.4 Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.4.5 Pharmaron Beijing Recent Developments
11.5 ICON
11.5.1 ICON Company Information, Head Office, Market Area, and Industry Position
11.5.2 ICON Company Profile and Main Business
11.5.3 ICON Biopharmaceutical CRO Models, Specifications, and Application
11.5.4 ICON Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.5.5 ICON Recent Developments
11.6 PPD
11.6.1 PPD Company Information, Head Office, Market Area, and Industry Position
11.6.2 PPD Company Profile and Main Business
11.6.3 PPD Biopharmaceutical CRO Models, Specifications, and Application
11.6.4 PPD Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.6.5 PPD Recent Developments
11.7 BioPharma Services
11.7.1 BioPharma Services Company Information, Head Office, Market Area, and Industry Position
11.7.2 BioPharma Services Company Profile and Main Business
11.7.3 BioPharma Services Biopharmaceutical CRO Models, Specifications, and Application
11.7.4 BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.7.5 BioPharma Services Recent Developments
11.8 TriStar Technology Group
11.8.1 TriStar Technology Group Company Information, Head Office, Market Area, and Industry Position
11.8.2 TriStar Technology Group Company Profile and Main Business
11.8.3 TriStar Technology Group Biopharmaceutical CRO Models, Specifications, and Application
11.8.4 TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.8.5 TriStar Technology Group Recent Developments
11.9 Fortrea
11.9.1 Fortrea Company Information, Head Office, Market Area, and Industry Position
11.9.2 Fortrea Company Profile and Main Business
11.9.3 Fortrea Biopharmaceutical CRO Models, Specifications, and Application
11.9.4 Fortrea Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.9.5 Fortrea Recent Developments
11.10 Eurofins BioPharma Services
11.10.1 Eurofins BioPharma Services Company Information, Head Office, Market Area, and Industry Position
11.10.2 Eurofins BioPharma Services Company Profile and Main Business
11.10.3 Eurofins BioPharma Services Biopharmaceutical CRO Models, Specifications, and Application
11.10.4 Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.10.5 Eurofins BioPharma Services Recent Developments
11.11 Medicilon
11.11.1 Medicilon Company Information, Head Office, Market Area, and Industry Position
11.11.2 Medicilon Company Profile and Main Business
11.11.3 Medicilon Biopharmaceutical CRO Models, Specifications, and Application
11.11.4 Medicilon Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.11.5 Medicilon Recent Developments
11.12 Asymchem
11.12.1 Asymchem Company Information, Head Office, Market Area, and Industry Position
11.12.2 Asymchem Company Profile and Main Business
11.12.3 Asymchem Biopharmaceutical CRO Models, Specifications, and Application
11.12.4 Asymchem Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.12.5 Asymchem Recent Developments
11.13 UBC
11.13.1 UBC Company Information, Head Office, Market Area, and Industry Position
11.13.2 UBC Company Profile and Main Business
11.13.3 UBC Biopharmaceutical CRO Models, Specifications, and Application
11.13.4 UBC Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.13.5 UBC Recent Developments
11.14 SanaClis
11.14.1 SanaClis Company Information, Head Office, Market Area, and Industry Position
11.14.2 SanaClis Company Profile and Main Business
11.14.3 SanaClis Biopharmaceutical CRO Models, Specifications, and Application
11.14.4 SanaClis Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.14.5 SanaClis Recent Developments
11.15 TFS HealthScience
11.15.1 TFS HealthScience Company Information, Head Office, Market Area, and Industry Position
11.15.2 TFS HealthScience Company Profile and Main Business
11.15.3 TFS HealthScience Biopharmaceutical CRO Models, Specifications, and Application
11.15.4 TFS HealthScience Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.15.5 TFS HealthScience Recent Developments
11.16 Parexel
11.16.1 Parexel Company Information, Head Office, Market Area, and Industry Position
11.16.2 Parexel Company Profile and Main Business
11.16.3 Parexel Biopharmaceutical CRO Models, Specifications, and Application
11.16.4 Parexel Biopharmaceutical CRO Revenue and Gross Margin, 2020-2025
11.16.5 Parexel Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Biopharmaceutical CRO should grow from US$ 30038 million in 2024 to US$ 46902 million by 2031, with a CAGR of 6.7% for the period of 2025-2031.

Contract Research Organizations (CROs) in the biopharmaceutical industry provide outsourced R&D and clinical services for biologics and biopharmaceuticals, including preclinical research, cell line construction, bioprocess optimization, analytical testing, clinical operations, and regulatory support. The gross profit margin of major companies in the industry ranges from 20% to 35%. The upstream of the biopharmaceutical CRO industry chain mainly includes drug development clients (such as large pharmaceutical companies, biotechnology companies, and early-stage pharmaceutical startups) and research support resources (such as universities, research institutes, and reagent and instrument suppliers). These entities provide R&D goals, funding, and basic research results. The midstream consists of the CRO companies themselves, covering the entire outsourcing process from drug discovery, preclinical research, clinical trial management to registration and post-marketing monitoring. Their core capabilities lie in their professional teams, technology platforms, and project management efficiency. The downstream extends to drug regulatory agencies (such as the FDA and NMPA), medical institutions, patient groups, and commercialization partners. With the rising costs of new drug development and the increasing specialization of labor, CROs, as a key hub connecting the source of innovation and industrial transformation, continue to enhance their strategic position in the global biopharmaceutical ecosystem.

Biopharmaceutical CRO

According to YH Research, the global market for Biopharmaceutical CRO should grow from US$ 30038 million in 2024 to US$ 46902 million by 2031, with a CAGR of 6.7% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The biopharmaceutical CRO market continues to grow as drug developers increasingly outsource R&D to shorten development cycles and reduce costs. Rising demand for biologics, gene therapies, and mRNA platforms is driving the need for specialized expertise in cell lines, bioprocessing, and regulatory pathways. CROs are investing in digital clinical trials, AI-driven molecule design, and automated laboratories to enhance efficiency. Globalization of clinical trials and expansion in emerging markets create new opportunities for large players. Overall, the industry is shifting toward full-service, integrated solutions covering discovery to commercialization.

This report studies and analyses global Biopharmaceutical CRO status and future trends, to help determine the Biopharmaceutical CRO market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CRO, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Biopharmaceutical CRO market size, history data 2019-2024, and forecast data 2025 -2030, (US$ million)
(2) Global Biopharmaceutical CRO by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Biopharmaceutical CRO by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Biopharmaceutical CRO key consuming regions, consumption value and demand structure
(5) Biopharmaceutical CRO industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    WuXi AppTec
    WuXi Biologics
    Hangzhou Tigermed
    Pharmaron Beijing
    ICON
    PPD
    BioPharma Services
    TriStar Technology Group
    Fortrea
    Eurofins BioPharma Services
    Medicilon
    Asymchem
    UBC
    SanaClis
    TFS HealthScience
    Parexel

Market segment by Type, covers
    Full-service CRO
    Specialized CRO

Market segment by Application, can be divided into
    SMBs
    Large Enterprises

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Biopharmaceutical CRO product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Biopharmaceutical CRO market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Biopharmaceutical CRO market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Biopharmaceutical CRO industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2019-2030
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2019-2030
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions